This analysis revealed that high levels of KIFC1 (p = 0.04; HR 1.84), KIF11 (p = 0.03; HR 1.88), KIF14 (p = 0.03; HR 1.91) and KIF20A (p = 0.01; HR 2.13) were associated with a shorter progression-free survival, suggesting kinesins as novel prognostic factors in meningiomas. Here, KIF20A is linked to meningioma.